Non-motor symptoms in treated and untreated chinese patients with early parkinson's disease

Tohoku Journal of Experimental Medicine

Volumn 232, Issue 2, 2014, Pages 129-136

  Zhang, Hui ^a   Gu, Zhuqin ^b   An, Jing ^a   Wang, Chaodong ^a   Chan, Piu ^a,b,c,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d Beijing Key Laboratory for Parkinson's Disease   (China)

Author keywords

Antiparkinsonian medication; Chinese patients; Dopaminergic treatment; Non motor symptoms; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PIRIBEDIL; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CHINESE; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; GENDER; HOEHN AND YAHR SCALE; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NON MOTOR SYMPTOM; ONSET AGE; PARKINSON DISEASE; PREVALENCE; PRODROMAL SYMPTOM; SLEEP DISORDER; SYMPTOMATOLOGY;

AGE FACTORS; ANTIPARKINSON AGENTS; CHINA; COHORT STUDIES; CONSTIPATION; DEPRESSION; DOPAMINE AGONISTS; HUMANS; LEVODOPA; LOGISTIC MODELS; PARKINSON DISEASE; SEX FACTORS; SLEEP DISORDERS; TIME FACTORS;

EID: 84897009407     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.232.129     Document Type: Article

References (19)

1. Baldwin, D.S. & Papakostas, G.I. (2006) Symptoms of fatigue and sleepiness in major depressive disorder. J. Clin. Psychiatry, 67 Suppl 6, 9-15
2. Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T.P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., Cicarelli, G., Gaglio, R.M., Giglia, R.M., Iemolo, F., Manfredi, M., et al. (2009) The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov. Disord., 24, 1641-1649
3. Braak, H., Del Tredici, K., Rüb, U., de Vos, R.A., Jansen Steur, E.N. & Braak, E. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging, 24, 197-211
4. Chaudhuri, K.R. & Schapira, A.H. (2009) Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol., 8, 464-474
5. Cools, R., Baker, R.A., Sahakian, B.J. & Robbins, T.W. (2001) Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex, 11, 1136-1143
6. Drijgers, R.L., Verhey, F.R., Tissingh, G., van Domburg, P.H., Aalten, P. & Leentjens, A.F. (2012) The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate. J. Neurol. Sci., 320, 121-126
7. Duncan, G.W., Khoo, T.K., Yarnall, A.J., O'Brien, J.T., Coleman, S.Y., Brooks, D.J., Barker, R.A. & Burn, D.J. (2013) Healthrelated quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Mov. Disord., [Epub ahead of print].
8. Eggert, K., Schrader, C., Hahn, M., Stamelou, M., Rüssmann, A., Dengler, R., Oertel, W. & Odin, P. (2008) Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and nonmotor complications. Clin. Neuropharmacol., 31, 151-166
9. Honig, H., Antonini, A., Martinez-Martin, P., Forgacs, I., Faye, G.C., Fox, T., Fox, K., Mancini, F., Canesi, M., Odin, P. & Chaudhuri, K.R. (2009) Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov. Disord., 24, 1468-1474
10. Laloux, C., Derambure, P., Houdayer, E., Jacquesson, J.M., Bordet, R., Destée, A. & Monaca, C. (2008) Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice. J. Sleep Res., 17, 101-110
11. Litvan, I., Bhatia, K.P., Burn, D.J., Goetz, C.G., Lang, A.E., McKeith, I., Quinn, N., Sethi, K.D., Shults, C. & Wenning, G.K.; Movement Disorders Society Scientific Issues Committee. (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov. Disord., 18, 467-486
12. Monti, J.M., Jantos, H. & Fernández, M. (1989) Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur. J. Pharmacol., 169, 61-66
13. Navailles, S., Benazzouz, A., Bioulac, B., Gross, C. & De Deurwaerdère, P. (2010a) High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. J. Neurosci., 30, 2356-2364
14. Navailles, S., Bioulac, B., Gross, C. & De Deurwaerdère, P. (2010b) Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease. Neurobiol. Dis., 38, 136-143
15. Politis, M., Piccini, P., Pavese, N., Koh, S.B. & Brooks, D.J. (2008) Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study. Exp. Neurol., 214, 112-116
16. Sakakibara, R., Uchiyama, T., Yamanishi, T., Shirai, K. & Hattori, T. (2008) Bladder and bowel dysfunction in Parkinson's disease. J. Neural Transm., 115, 443-460
17. Tomlinson, C.L., Stowe, R., Patel, S., Rick, C., Gray, R. & Clarke, C.E. (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov. Disord., 25, 2649-2653
18. Trenkwalder, C., Kies, B., Rudzinska, M., Fine, J., Nikl, J., Honczarenko, K., Dioszeghy, P., Hill, D., Anderson, T., Myllyla, V., Kassubek, J., Steiger, M., Zucconi, M., Tolosa, E., Poewe, W., et al. (2011) Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a doubleblind, randomized, placebo-controlled study (RECOVER). Mov. Disord., 26, 90-99
19. Wolters, E.Ch. & Braak, H. (2006) Parkinson's disease: premotor clinico-pathological correlations. J. Neural Transm. Suppl.